Clinical TrialsSearch results
Number of results: 521
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Multicentric study of inhaled corticosteroid and theophylline in asthma
- Bronchial asthma
- Graduate school of biomedical sciences, Hiroshima university, department of molecular and internal medicine
- 2006-04-01
Other
- Multicenter Phase II Randomized Controlled Trial of S-1 and Interferon-alpha Combined Chemotherapy or S-1 Alone in Advanced Hepatocellular Carcinoma with Extrahepatic Metastasis
- Advanced hepatocellular carcinoma with extrahepatic metastasis
- Graduate School of Medicine, Osaka University Department of Surgery
- 2007-07-26
Recruiting
- Comparison between ABP 234 and Keytruda (Pembrolizumab)
- Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
- Haby Henary
- 2024-06-18
Completed
- Effects of Hochuekkito in apathetic patients with chronic obstructive pulmonary disease who receive pulmonary rehabilitation
- Chronic obstructive pulmonary disease
- Hamada Hironobu
- 2019-03-08
Completed
- Safety test of sensory stimulation treatment for head and neck cancer patients
- head and neck cancer
- Hamamoto Takao
- 2022-04-13
Completed
- A pilot study of pembrolizumab in elderly patients with non-small cell lung cancer
- Lung Cancer
- Hattori Noboru
- 2019-03-19
Recruiting
- Phase II study of combination treatment of nivolumab and TM5614 for non-small cell lung cancer (TM-Uprise Study)
- non-small cell lung cancer
- Hattori Noboru
- 2023-07-19
Completed
- Phase 3 Randomized, Double- Blind,Placebo Controlled, MulticenterStudy to Compare the Efficacy and Safety of Lenalidomide(CC-5013) PlusR- CHOP Chemotherapy (R2-CHOP)Versus Placebo Plus R- CHOP Chemotherapy in Subjects with Previously UntreatedActivated B- cell Type Diffuse Large B- cell Lymphoma
- Previously untreated, activated B-cell (ABC) type diffuse large B- cell lymphoma
- Hayakawa Jin
- 2023-03-02
Recruiting
- A Phase III, Randomized, Open-Label, Multicenter, Global Study of Volrustomig (MEDI5752) in Combination With Carboplatin Plus Pemetrexed Versus Platinum Plus Pemetrexed or Nivolumab Plus Ipilimumab in Participants With Unresectable Pleural Mesothelioma.
- Unresectable Pleural Mesothelioma
- Hibi Kazushige
- 2023-11-11
Other
- Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC
- Esophageal Squamous Cell Carcinoma
- Hibi Kazushige
- 2020-11-04